Trials / Completed
CompletedNCT01789905
Tygacil Drug Use Investigation
Tygacil Drug Use Investigation (Tigecycline Evaluation Study For Safety And Effectiveness In Patient Infected With Multi-Drug Resistance.)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 116 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Secondary Data Collection Study; safety and effectiveness of Tigecycline .under Japanese medical practice
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tigecycline (Tygacil) | Tigecycline 50 mg intravenously. Therapy conducted according to Japanese LPD of Tygacil. Tygacil will be dosed according to labeling. The administration and duration of the therapy will be determined by the treating physician to meet the patient individual needs for treatment. |
Timeline
- Start date
- 2013-04-15
- Primary completion
- 2017-06-16
- Completion
- 2017-06-16
- First posted
- 2013-02-12
- Last updated
- 2019-02-06
- Results posted
- 2018-12-24
Source: ClinicalTrials.gov record NCT01789905. Inclusion in this directory is not an endorsement.